Dr. Hart on Impact of Trilaciclib on Myelosuppression in Extensive-Stage SCLC
August 30th 2019Lowell L. Hart, MD, FACP, scientific director of Clinical Research at Florida Cancer Specialists and Research Institute, and associate professor of Internal Medicine at Wake Forest School of Medicine, discusses the impact of trilaciclib on myelosuppression in patients with previously treated extensive-stage small cell lung cancer.
Read More
Dr. Hart on Advances in ALK+ NSCLC
December 1st 2016Lowell L. Hart, MD, scientific director of Research at Florida Cancer Specialists and Research Institute, and associate professor of Internal Medicine at Wake Forest School of Medicine, discusses the recent advances in the area of ALK-positive non–small cell lung cancer.
Read More